Armistice Capital, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Armistice Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $43.6 Million - $76.5 Million	-524,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $6.16 Million - $8 Million	56,000 Added 11.97%	524,000 $62.1 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $9.18 Million - $13.7 Million	92,000 Added 24.47%	468,000 $64.5 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $12.3 Million - $17.2 Million	-124,000 Reduced 24.8%	376,000 $52.2 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $32.9 Million - $52.5 Million	-500,000 Reduced 50.0%	500,000 $48.5 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $27.4 Million - $39.3 Million	428,000 Added 74.83%	1,000,000 $68.4 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $21.3 Million - $32.2 Million	-328,000 Reduced 36.44%	572,000 $49 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $23.6 Million - $31.2 Million	400,000 Added 80.0%	900,000 $58.5 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $16.1 Million - $41.3 Million	-556,000 Reduced 52.65%	500,000 $36.6 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $12.2 Million - $25.4 Million	444,000 Added 72.55%	1,056,000 $35.9 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $1.39 Million - $1.96 Million	34,000 Added 5.88%	612,000 $33.3 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $15.6 Million - $20.7 Million	418,000 Added 261.25%	578,000 $24.1 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $6.37 Million - $10.7 Million	160,000 New	160,000 $7.01 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.67B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.